Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
03/2003
03/13/2003CA2457534A1 Substituted indeno[1,2-c]isoquinoline derivatives and methods of use thereof
03/13/2003CA2452044A1 Pre-mixes of glp-1 and basal insulin
03/12/2003EP1291430A1 Ceramide kinase and dna encoding the same
03/12/2003EP1291429A1 Novel enzyme gene and its expression product
03/12/2003EP1291360A1 Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
03/12/2003EP1291349A1 Malto-oligosaccharide derivatives and use thereof
03/12/2003EP1291346A1 Process for the preparation of trisubstituted imidazole compounds with multiple therapeutic properties
03/12/2003EP1291022A1 Methods of using lanreotide, a somatostatin analogue
03/12/2003EP1291021A2 Pharmaceutical formulations for thyroid hormones
03/12/2003EP1291019A1 Biologically active agents and drugs
03/12/2003EP1291015A1 Dosage forms having prolonged active ingredient release
03/12/2003EP1290449A1 Use of the g protein coupled receptor gpr3 to identify apetite control agents
03/12/2003EP1290227A1 Compositions, kits, and methods for identification and modulation of type i diabetes
03/12/2003EP1290206A2 Recombinant aav vectors for gene therapy of obesity
03/12/2003EP1290204A1 Antisense modulation of c/ebp alpha expression
03/12/2003EP1290193A2 Protein phosphatases
03/12/2003EP1290187A2 Humain kinases
03/12/2003EP1290180A2 Drug metabolizing enzymes
03/12/2003EP1290174A2 G-protein coupled receptor org3.
03/12/2003EP1290170A2 Binding agents: chimeric ligand/receptor proteins
03/12/2003EP1290169A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
03/12/2003EP1290154A2 The identification and use of effectors and allosteric molecules for the alteration of gene expression
03/12/2003EP1290143A2 Method to determine the differentiation potential of a target cell
03/12/2003EP1290033A1 Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
03/12/2003EP1290024A1 Glucose dependent release of insulin from glucose sensing insulin derivatives
03/12/2003EP1290013A2 Apo-ai/aii peptide derivatives
03/12/2003EP1289997A1 Macrolides
03/12/2003EP1289993A1 Caspase inhibitors and uses thereof
03/12/2003EP1289983A2 Heteroarylalkanoic acids as integrin receptor antagonists
03/12/2003EP1289982A1 Bioisosteric benzamide derivatives and their use as apob-100 secretion inhibitors
03/12/2003EP1289971A1 Benzamide derivatives and their use as apob-100 and mtp inhibitors
03/12/2003EP1289965A1 Substituted 1-aminoalkyl-lactams and their use as muscarinic receptor antagonists
03/12/2003EP1289960A2 Cycloalkyl alkanoic acids as integrin receptor antagonists
03/12/2003EP1289959A1 Dihydrostilbene alkanoic acid derivatives useful as vitronectin antagonists
03/12/2003EP1289955A1 Piperidines for use as orexin receptor antagonists
03/12/2003EP1289951A1 Growth hormone secretagogues
03/12/2003EP1289944A2 Thioketals and thioethers for inhibiting the expression of vcam-1
03/12/2003EP1289936A1 Substituted stilbenes as glucose uptake enhancers
03/12/2003EP1289931A1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
03/12/2003EP1289573A1 A medicinal aerosol formulation
03/12/2003EP1289561A2 Ligand conjugates and methods for preparing same
03/12/2003EP1289559A1 Combinations of enzyme inhibitor-containing preparations and the use thereof
03/12/2003EP1289558A2 Combinations of an endothelin receptor antagonist and an antiepileptic compound having pain alleviating properties or analgesic
03/12/2003EP1289556A2 Phytoestrogenic isoflavone compositions
03/12/2003EP1289534A2 Apoptotic entities for use in treatment of t-cell-mediated and inflammatory disorders
03/12/2003EP1289531A2 Kits and methods for optimizing the efficacy of chondroprotective compositions
03/12/2003EP1289526A1 Melanocortin receptor agonists
03/12/2003EP1289519A1 Methods of treating androgen deficiency in men using selective antiestrogens
03/12/2003EP1289507A1 Use of an aldosterone antagonist for the treatment or prohpylaxis of aldosterone-mediated pathogenic effects
03/12/2003EP1263418A4 Cartilage enhancing food supplements and methods of preparing the same
03/12/2003EP0858335B1 2-alkylpyrrolidines
03/12/2003EP0831881B1 Cetp for increasing hdl cholesterol level
03/12/2003CN1402733A Angiogenic proteins and uses thereof
03/12/2003CN1402732A Nb heterocyclic 8-modified adenosine derivs.
03/12/2003CN1402729A Polycycloalkylpurines as adenosine receptor antagonists
03/12/2003CN1402724A Thiazolidinedione derivs. as antidiabetic agents
03/12/2003CN1402721A Benzoimidazole derivs. useful as antiproliferative agents
03/12/2003CN1402720A 2,4-diaminopyrimidine compounds useful as immunosuppressants
03/12/2003CN1402716A Substd. oxazoles and thiazoles derivs. as HPPAR alpha activators
03/12/2003CN1402712A Novel heterocyclic compounds and salts thereof and medicinal use of same
03/12/2003CN1402711A 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as CETP inhibitor
03/12/2003CN1402706A Antidiabetic agents
03/12/2003CN1402704A Comminuted form of (S)-2-ethoxy-3-[4-(2-{4-methane-sulfonyloxyphenyl} ethoxy) phenyl] propanoic acid
03/12/2003CN1402703A Tri-substd. phenyl derivs. and analogues
03/12/2003CN1402702A Beta 2-adrenergic receptor agonists
03/12/2003CN1401388A Child 'Xuebao' chewing tablet and preparing process thereof
03/12/2003CN1401379A Hypoglycemic tea and preparing process thereof
03/12/2003CN1401371A 'Shenhuaxiaokecha' tea and preparing method thereof
03/12/2003CN1401368A Greater celandine extract herbal preparation for treating diabetes
03/12/2003CN1401339A Oral liquid capable of reducing blood fat and improving symptom of myocardial ischemia and infarction
03/12/2003CN1401329A Oral Selenium supplement agent using bimetallic oxide as carrier, and preparing process and use method thereof
03/12/2003CN1401318A Chinese traditional medicine hypoglycemic agent and preparing process thereof
03/12/2003CN1102847C Medicine or nutrient contg. daidzein material
03/11/2003USRE38027 Preparation of agarose coated, solid agarose-collagen beads containing secretory cells
03/11/2003US6531622 Crytalline form of (s)-2 ethoxy -3-[4-(2-{4- methanesulfonyloxyphenyl} ethoxy)phenyl]propanoic acid
03/11/2003US6531609 Process for the preparation of thiazolidinedione derivatives
03/11/2003US6531511 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
03/11/2003US6531507 Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
03/11/2003US6531492 Heterocyclo-alkylsulfonyl pyrazole derivatives as anti-inflammatory/analgesic agents
03/11/2003US6531478 For therapy of eating disorder, obesity, bulimia nervosa, diabetes, binge eating, anorexia nervosa, dyslipidimia, hypertension, memory loss, epileptic seizures, migraine, sleep disturbances, pain, sexual/reproductive disorders
03/11/2003US6531471 Morpholinone and morpholine derivatives and uses thereof
03/11/2003US6531468 Inhibiting serotonin reuptake in the central nervous system of a mammal
03/11/2003US6531463 Dissolving starting material containing beta-sitosterol or beta-sitosterol and beta-sitostanol in oil and/or fat by heating, cooling mixture, adding water at same temperature, agitating to form homogeneous and stable dispersion
03/11/2003US6531460 Vitamin D, derivatives and remedies for inflammatory respiratory diseases containing the same
03/11/2003US6531459 Vitamin D derivatives with phosphorus atoms in the side chains
03/11/2003US6531450 Use treating neuropathological situations caused by the aging of the nervous system; MP52, MP121 are growth or/and differentiation factors of the TGF-beta (transforming growth factor) superfamily
03/11/2003US6531449 Hexahydropyrazolo[4,3,-c]pyridine metabolites
03/11/2003US6531448 Composition comprising protein selected from insulin, insulin analog, and proinsulin; derivatized protein selected from fatty acid-acylated insulins; complexing compound; hexamer stabilizing compound; and divalent metal cation
03/11/2003US6531157 The present invention relates to stable emulsions and dry powders of mixtures of fat-soluble vitamins, and to processes for their preparation and to their use.
03/11/2003US6531129 Heparanase specific molecular probes and their use in research and medical applications
03/11/2003CA2242351C Novel tricyclic compounds and drug compositions containing the same
03/11/2003CA2038416C Ascorbic acid derivatives
03/07/2003WO2002020472A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/07/2003CA2421781A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
03/06/2003WO2003019146A2 High throughput screening assays using fatty acid synthetic enzymes
03/06/2003WO2003018823A1 Obesity related genes expressed at least in the hypotalamus, liver or pancreas
03/06/2003WO2003018803A1 Established fat cell precursors, method of preparing the same and method of using the same
03/06/2003WO2003018759A2 Phenylalanine ammonia lyase polypeptide and polynucleotide sequences and methods of obtaining and using same
03/06/2003WO2003018756A2 Methods for preparing purified prostaglandin e synthase
03/06/2003WO2003018636A2 Chimaeric peptides of insulin, their compositions and use in treating diabetes
1 ... 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 ... 1298